• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MedAmicus to sell Schick densitometer

Article

Medical technology firm MedAmicus has signed an agreement with Schick Technologies to distribute that firm's accuDEXA bone densitometer (SCAN 4/15/98). MedAmicus, of Plymouth, MN, will add accuDEXA to its line of diagnostic testing products it

Medical technology firm MedAmicus has signed an agreement with Schick Technologies to distribute that firm's accuDEXA bone densitometer (SCAN 4/15/98). MedAmicus, of Plymouth, MN, will add accuDEXA to its line of diagnostic testing products it sells to physicians' offices. The company will price the densitometer at under $13,000, with shipments expected to begin by the end of April.

In other Schick news, the Long Island City, NY, company reported on April 14 that it expects revenues for its fourth quarter (end-March) to be between $12 million and $13 million. The figures are much higher than the $5.4 million in sales Schick recorded in the same period last year, but are short of expectations due to the late delivery of components from a supplier, which prevented Schick from fulfilling orders worth between $2 million and $3 million. The delays have been resolved, and the products should ship in its first fiscal quarter, according to Schick.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.